Gracell Biotechnologies Inc. (GRCL) is a leading biopharmaceutical company focusing on developing and commercializing cell therapies for cancer treatment. With advancements in gene editing and cell manufacturing technologies, the company aims to provide safer and more effective treatments for patients. GRCL’s innovative approach and strong pipeline make it a key player in the rapidly growing cell therapy market.
